Achieve Life Sciences, Inc. Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31)
Achieve Life Sciences, Inc. (ACHV) reported Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) of $0 for the 9-month period ending 2013-09-30, per its 10-Q filed 2013-11-07.
Discontinued › Income Statement › Other Income
us-gaap:MarketableSecuritiesRealizedGainLossOtherThanTemporaryImpairmentsAmount · last filed 2013-11-07
- Achieve Life Sciences, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2013-09-30 was $0.00.
- Achieve Life Sciences, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2013-06-30 was $0.00.
- Achieve Life Sciences, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2013-03-31 was $0.00.
- Achieve Life Sciences, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for the quarter ending 2012-12-31 was $0.00.
- Achieve Life Sciences, Inc. marketable securities, realized loss, other than temporary impairments, amount (deprecated 2018-01-31) for fiscal 2012 was $0.00.
| Period end | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 3 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 6 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 9 month | Marketable Securities, Realized Loss, Other than Temporary Impairments, Amount (Deprecated 2018-01-31) 12 month |
|---|---|---|---|---|
| 2013-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2013-11-07 | $0.00 derived: sum of 2 quarters · filed 2013-11-07 | $0.00 10-Q · filed 2013-11-07 | $0.00 derived: sum of 4 quarters · filed 2013-11-07 |
| 2013-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2013-08-08 | $0.00 10-Q · filed 2013-08-08 | $0.00 derived: sum of 3 quarters · filed 2013-08-08 | $0.00 derived: sum of 4 quarters · filed 2013-08-08 |
| 2013-03-31 | $0.00 10-Q · filed 2013-05-02 | $0.00 derived: sum of 2 quarters · filed 2013-05-02 | $0.00 derived: sum of 3 quarters · filed 2013-05-02 | |
| 2012-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2013-03-07 | $0.00 derived: sum of 2 quarters · filed 2013-03-07 | $0.00 10-K · filed 2013-03-07 | |
| 2012-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2012-11-08 | $0.00 10-Q · filed 2012-11-08 | ||
| 2012-06-30 | $0.00 10-Q · filed 2012-08-02 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| VOLITIONRX LTD (VNRX) | $0.003B | -0.64 | |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |